17 May 2025 : Clinical Research
Pre-Chemotherapy D-Dimer Levels as Predictors of Survival Outcomes in Advanced Gastric Cancer
Yali Du ABCDEFG 1, Xuebing Jiang AD 1, Kaifei Fu ACF 1, Chengwen Cui ACDEF 2*DOI: 10.12659/MSM.947727
Med Sci Monit 2025; 31:e947727
Table 4 Difference in D-dimer levels.
| Response | Pre-PSM (n=134) | Post-PSM (n=86) | ||||
|---|---|---|---|---|---|---|
| Pretreatment | At the first response evaluation | P# | Pretreatment | At the first response evaluation | P# | |
| PR+SD | 2.46±4.07 | 2.01±2.94 | 0.499 | 2.80±3.45 | 2.35±3.34 | 0.241 |
| PD | 2.52±3.82 | 3.73±5.43 | 0.113 | 3.05±4.22 | 4.26±6.00 | 0.387 |
| P | 0.698 | 0.006 | 0.931 | 0.039 | ||
| PD – progressive disease; PR – partial response; SD – stable disease. The P values are calculated by Wilcoxon signed-rank test on the difference in D-dimer levels between at the pretreatment and the first response evaluation. The P values are calculated by Wilcoxon signed-rank test on the difference in D-dimer levels between at the response PD and PR+SD. | ||||||